12.07.2015 Views

Combining health and social protection measures to reach the ultra ...

Combining health and social protection measures to reach the ultra ...

Combining health and social protection measures to reach the ultra ...

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Decision-makingChallenges in employing systematic reviewsfor <strong>health</strong> policy-makingWhile in principle systematic reviews have much <strong>to</strong> offer <strong>the</strong>policy-maker, in practice, at this point in time, <strong>the</strong>re are somereal challenges in terms of <strong>the</strong>ir use in policy development.Four main challenges are described <strong>and</strong> addressed here,namely:✜ addressing non-effectiveness questions;✜ making decisions when evidence is scarce;✜ adapting international evidence <strong>to</strong> local contexts;✜ combining systematic review evidence with o<strong>the</strong>r types ofinformation.Broadening out from effectiveness questions – over <strong>the</strong>last two decades, scientists have established a reasonableconsensus regarding “best practice” for systematic reviewsthat inform clinical decision-making regarding effectiveness,as well as public policy-making regarding adoption, use <strong>and</strong>discontinuation of <strong>health</strong> technologies. These methods relyheavily on <strong>the</strong> use of hierarchies of levels of evidence, withr<strong>and</strong>omized controlled trials given <strong>the</strong> greatest weight.Statistical methods (meta-analysis) may or may not be used<strong>to</strong> analyse <strong>and</strong> summarise <strong>the</strong> results of <strong>the</strong> included studies.However, many of <strong>the</strong> questions which policy-makers raiseregarding <strong>health</strong> systems do not concern whe<strong>the</strong>r or not aparticular strategy works, but ra<strong>the</strong>r, how it should best beimplemented, or how it might be perceived by stakeholders.Increasingly, systematic review methodologies have beenapplied <strong>to</strong> questions o<strong>the</strong>r than those about <strong>the</strong> effectivenessof interventions, however <strong>the</strong>re is less consensus about <strong>the</strong>methodologies for conducting such reviews 3 . If systematicreviews are <strong>to</strong> be used <strong>to</strong> help policy-makers address difficultdecisions regarding <strong>health</strong> systems, <strong>the</strong>n greatermethodological consensus <strong>and</strong> clarity on addressing noneffectivenessquestions is required.Making decisions when evidence is scarce – as notedabove, systematic reviews have typically focused uponsyn<strong>the</strong>sizing findings from studies that have usedexperimental designs. However in <strong>the</strong> field of <strong>health</strong> policy<strong>and</strong> systems research, relatively limited evidence is generatedthrough r<strong>and</strong>omized controlled trials. In such circumstances,systematic reviews must rely more heavily on nonexperimentalanalyses including controlled before/afterstudies <strong>and</strong> interrupted time-series studies. Althoughmethods are available for syn<strong>the</strong>sizing findings from suchstudies, <strong>the</strong>y are less well known <strong>and</strong> less well developedthan those for syn<strong>the</strong>sizing findings from r<strong>and</strong>omized studies.But even if this broader range of study designs are includedin <strong>the</strong> review, in many instances very few studies areavailable. For example, Lagarde <strong>and</strong> Palmer 4 conducted asystematic review of various <strong>health</strong> financing mechanisms,focusing only on studies conducted in low- <strong>and</strong> middleincomecountry contexts. For many of <strong>the</strong> mechanisms which<strong>the</strong>y were interested in, <strong>the</strong>re were very few studies that met<strong>the</strong>ir inclusion criteria 5 , for example no studies were found of<strong>social</strong> <strong>health</strong> insurance mechanisms, one was found forcommunity-based <strong>health</strong> insurance, <strong>and</strong> three for contractingout of <strong>health</strong> services. When so few studies are available, <strong>the</strong>information syn<strong>the</strong>sized can be frustratingly thin, <strong>and</strong> not veryhelpful <strong>to</strong> policy-makers. Systematic reviews may still beuseful, <strong>to</strong> at least point out <strong>the</strong> flimsy nature of <strong>the</strong> evidencebase supporting <strong>the</strong> policy or intervention being considered,<strong>and</strong> thus underscoring <strong>the</strong> need for <strong>the</strong> simultaneousimplementation of moni<strong>to</strong>ring <strong>and</strong> evaluation mechanisms <strong>to</strong>ensure that no harm is done through <strong>the</strong> policy. However thischallenge also implies: (a) that much greater investment isneeded in well-designed, rigorous, impact evaluations <strong>and</strong> (b)that development of methods for <strong>the</strong> syn<strong>the</strong>sis of o<strong>the</strong>r typesof study design should be accelerated, while acknowledgingthat, depending on <strong>the</strong> nature of <strong>the</strong> question being asked,<strong>the</strong>y may provide less reliable information.Adapting international evidence <strong>to</strong> local contexts – mostsystematic reviews review <strong>the</strong> international evidence base,yet, as described above, <strong>the</strong>re are major differences in <strong>the</strong><strong>health</strong> systems of different countries, <strong>and</strong> thus <strong>the</strong> effects thatalternative strategies <strong>to</strong> streng<strong>the</strong>n <strong>health</strong> systems might lead<strong>to</strong>. For example, Lewin et al 6 review <strong>the</strong> evidence on lay<strong>health</strong> workers. While <strong>the</strong>y found many articles 7 that met <strong>the</strong>irinclusion criteria, <strong>and</strong> <strong>the</strong>y concluded that <strong>the</strong>re was evidenceof moderate <strong>to</strong> high quality supporting <strong>the</strong> effectiveness of lay<strong>health</strong> workers in <strong>the</strong> provision of specific services such asimproving immunization uptake, <strong>and</strong> reducing childhoodmorbidity <strong>and</strong> mortality from common illnesses, <strong>the</strong> authorsnoted that for some services much of <strong>the</strong> available evidencecame from industrialized countries <strong>and</strong> it was not clearwhe<strong>the</strong>r <strong>the</strong> intervention effects would be transferable <strong>to</strong> o<strong>the</strong>rsettings. With respect <strong>to</strong> <strong>the</strong> effectiveness of lay <strong>health</strong>workers, differences in contextual fac<strong>to</strong>rs such as <strong>the</strong>availability of routine data, <strong>the</strong> availability of resources <strong>to</strong>provide clinical <strong>and</strong> managerial support, <strong>and</strong> <strong>the</strong> availabilityof drugs <strong>and</strong> accessible referral services are all likely <strong>to</strong> becritical. While some systematic reviews (e.g. Lagarde <strong>and</strong>Palmer 2007) focus on low- <strong>and</strong> middle-income countrycontexts alone, it is not clear that focusing only on studiesfrom countries with a particular economic status necessarilyleads <strong>to</strong> more relevant conclusions. Improved approaches <strong>to</strong>ensuring <strong>and</strong> assessing <strong>the</strong> transferability of review findingsare needed.Faced with a review that syn<strong>the</strong>sizes evidence from avariety of potentially very different country contexts, policymakersneed <strong>to</strong> question whe<strong>the</strong>r <strong>the</strong>re are important relevantdifferences in <strong>the</strong> structure of <strong>the</strong> <strong>health</strong> system, <strong>the</strong> on-<strong>the</strong>groundrealities <strong>and</strong> constraints, <strong>the</strong> epidemiologicalconditions, or <strong>the</strong> perspectives of <strong>health</strong> system stakeholders,that might mean that <strong>the</strong> review findings are not transferable<strong>to</strong> <strong>the</strong> context where <strong>the</strong>y are being considered. Policymakers,or policy analysts both need sufficient skills <strong>to</strong> makethis assessment <strong>and</strong> be provided with sufficient informationwithin <strong>the</strong> review for <strong>the</strong>m <strong>to</strong> be able <strong>to</strong> assess transferability.A fur<strong>the</strong>r fac<strong>to</strong>r regarding <strong>the</strong> transferability of findingsregards <strong>the</strong> scale at which <strong>the</strong> intervention was implemented;often systematic reviews of effectiveness questions capturedata from impact evaluations of small scale, experimentalinterventions. Some interventions may be effective ifGlobal Forum Update on Research for Health Volume 4 ✜ 149

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!